On the Pharmacology of Farnesoid X Receptor Agonists: Give me an “A”, Like in “Acid”
The Farnesoid X Receptor (FXR) has recently moved into the spotlight through the release of clinical data using Obeticholic Acid, an FXR agonist, that demonstrated effectiveness of this bile acid-like drug in patients with Primary Biliary Cirrhosis and Non-alcoholic Steatohepatitis (NASH). FXR holds...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KenzPub
2016-06-01
|
| Series: | Nuclear Receptor Research |
| Subjects: | |
| Online Access: | http://www.kenzpub.com/journals/nurr/2016/101207/ |